Amount$10M
Post-money valuation$20M
SeriesSeries A
AnnouncedNov 30, 2021
SectorHealthcare, Oncology, Life Sciences, Biotech
Solid
A solid round with healthy fundamentals.
Round size vs peers
In line with the typical Series A round.
Syndicate size
Single investor — limited external validation.
Insider conviction
All-new money — no prior investors re-upped.
Investor track record
Mostly newer or unproven managers.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series A rounds (995)
Round size distribution43th pct
smaller Series A roundslarger
Post-money valuation5th pct
$12Mthis round: $20M$1B
